Cargando…
Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas
BACKGROUND: Diffuse intrinsic pontine gliomas (DIPGs) are rare and fatal pediatric brainstem gliomas with no cure. Chimeric antigen receptor (CAR)-engineered natural killer (NK) cells have been proven effective in treating glioblastoma (GBM) in preclinical studies. However, there are no relevant stu...
Autores principales: | Zuo, Pengcheng, Li, Yaopeng, He, Chi, Wang, Tantan, Zheng, Xu, Liu, Hao, Wu, Zhen, Zhang, Junting, Liao, Xuebin, Zhang, Liwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213244/ https://www.ncbi.nlm.nih.gov/pubmed/37251413 http://dx.doi.org/10.3389/fimmu.2023.1145706 |
Ejemplares similares
-
Diffuse intrinsic pontine glioma: poised for progress
por: Warren, Katherine E.
Publicado: (2012) -
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
por: Bredlau, Amy Lee, et al.
Publicado: (2017) -
Genomic Insights into Diffuse Intrinsic Pontine Glioma
por: Lapin, Danielle H., et al.
Publicado: (2017) -
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
por: Chen, Yujia, et al.
Publicado: (2023) -
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
por: Mitwasi, Nicola, et al.
Publicado: (2020)